Company Clementia Pharmaceuticals Inc
Equities
CA1855751071
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
James M. Roach
CTO | Chief Tech/Sci/R&D Officer | 64 | - |
Jeffrey Packman
PRN | Corporate Officer/Principal | 57 | 13-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert A. Heft
BRD | Director/Board Member | 69 | 13-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,059,166 | 35,900,307 ( 94.33 %) | 0 | 94.33 % |
Company contact information
Clementia Pharmaceuticals, Inc.
1000 de la Gauchetière O bureau 1200
H3B 4W5, Montréal
+
https://www.ipsen.com/Sector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |